Issued Patents All Time
Showing 126–150 of 360 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 7232810 | 2-methylene-19-nor-vitamin D2 compounds | Rafal R. Sicinski, Sumithra Gowlugari | 2007-06-19 |
| 7214671 | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases | Lori A. Plum, Margaret Clagette-Dame | 2007-05-08 |
| 7214670 | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings | Lori A. Plum, Margaret Clagette-Dame | 2007-05-08 |
| 7208484 | Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol | Sumithra Gowlugari, Rafal R. Sicinski | 2007-04-24 |
| 7205286 | (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses | Rafal R. Sicinski, Pawel Grzywacz | 2007-04-17 |
| 7141558 | 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds | Rafal R. Sicinski | 2006-11-28 |
| 7126017 | Method of reducing toxicity of retinoids | Margaret Clagett-Dame, Margaret A. Highland | 2006-10-24 |
| 7115594 | Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase bone strength | Connie M. Smith | 2006-10-03 |
| 7112579 | 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds | Rafal R. Sicinski | 2006-09-26 |
| 7094916 | (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses | Rafal R. Sicinski, Pawel Grzywacz | 2006-08-22 |
| 7094776 | Method of locking 1α-OH of vitamin D compounds in axial orientation | Rafal R. Sicinski | 2006-08-22 |
| 7094774 | 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds | Rafal R. Sicinski | 2006-08-22 |
| 7071179 | Method of locking 1α-OH of vitamin D compounds in axial orientation | Rafal R. Sicinski | 2006-07-04 |
| 7064115 | (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses | Rafal R. Sicinski, Pawel Grzywacz | 2006-06-20 |
| 7056904 | Method of locking 1α-OH of vitamin D compounds in axial orientation | Rafal R. Sicinski | 2006-06-06 |
| 7053075 | Methods for reducing body fat using vitamin D compounds | Lori A. Plum, Hau Zhe Ke, Thomas A. Brown | 2006-05-30 |
| 7002019 | Synthesis of indole thiazole compounds as ligands for the Ah receptor | Pawel Grzywacz, Rafal R. Sicinski | 2006-02-21 |
| 6992074 | 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds | Rafal R. Sicinski | 2006-01-31 |
| 6939868 | Use of 2α-methly-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase bone strength | Connie M. Smith | 2005-09-06 |
| 6916834 | Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester | Jiasheng Song, Margaret Clagett-Dame, Richard E. Peterson, William M. Westler, Rafal R. Sicinski | 2005-07-12 |
| 6894037 | 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses | Pawel Grzywacz | 2005-05-17 |
| 6890914 | Method of locking 1α-OH of vitamin D compounds in axial orientation | Rafal R. Sicinski | 2005-05-10 |
| 6887860 | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses | Lori A. Plum, Margaret Clagett-Dame | 2005-05-03 |
| 6846811 | (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses | Rafal R. Sicinski, Pawel Grzywacz | 2005-01-25 |
| 6844332 | (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses | Rafal R. Sicinski, Pawel Grzywacz | 2005-01-18 |